Article
Structure of Bacterial 3β/17β-Hydroxysteroid Dehydrogenase at 1.2 Å Resolution: A Model for Multiple Steroid Recognition†,‡
This work was supported by grants from the Swedish Medical Research Council (13X-3532), the European Community (BIO4CT97-2123, TMR fellowship), Novo Nordisk Foundation (Denmark), Swedish Union of Physicians, and Karolinska Institutet.
The structural coordinates have been deposited with the Protein Data Bank under accession code 1hxh.
Present address: Department of Biological Sciences, Columbia University, 702 Fairchild Center, MC 2437, 1212 Amsterdam Avenue, New York, NY 10027.
Center for Structural Biochemistry, Karolinska Institutet NOVUM, SE−141 57 Huddinge, Sweden.
Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE−171 77 Stockholm, Sweden.
Global Phasing Ltd. Sheraton House, Castle Park, Cambridge CB30AX, UK.
Faculty of Natural Sciences, Södertörn University College, SE−141 04 Huddinge, Sweden.
In papers with more than one author, the asterisk indicates the name of the author to whom inquiries about the paper should be addressed.
Abstract
The enzyme 3β/17β-hydroxysteroid dehydrogenase (3β/17β-HSD) is a steroid-inducible component of the Gram-negative bacterium Comamonas testosteroni. It catalyzes the reversible reduction/dehydrogenation of the oxo/β-hydroxy groups at positions 3 and 17 of steroid compounds, including hormones and isobile acids. Crystallographic analysis at 1.2 Å resolution reveals the enzyme to have nearly identical subunits that form a tetramer with 222 symmetry. This is one of the largest oligomeric structures refined at this resolution. The subunit consists of a monomer with a single-domain structure built around a seven-stranded β-sheet flanked by six α-helices. The active site contains a Ser-Tyr-Lys triad, typical for short-chain dehydrogenases/reductases (SDR). Despite their highly diverse substrate specificities, SDR members show a close to identical folding pattern architectures and a common catalytic mechanism. In contrast to other SDR apostructures determined, the substrate binding loop is well-defined. Analysis of structure−activity relationships of catalytic cleft residues, docking analysis of substrates and inhibitors, and accessible surface analysis explains how 3β/17β-HSD accommodates steroid substrates of different conformations.
View: Full Text HTML | Hi-Res PDF
Tools
-
Add to Favorites
-
Download Citation
-
Email a Colleague -
Permalink
Order Reprints
Rights & Permissions
Citation Alerts
Accession Codes
History
- Published In Issue December 17, 2002
- Received May 17, 2002
Revised Manuscript Received August 19, 2002
Cart




